Anti-Müllerian hormone and antral follicle count predict ovarian response in women less than 45 years following GnRH antagonist multiple-dose protocol

Objective:To speculate which of the following parameters:antral follicle count(AFC),anti-Müllerian hormone(AMH),follicle-stimulating hormone(FSH)and age can be used as a predictor of ovarian response to gonadotropin-releasing hormone(GnRH)antagonist stimulation multiple-dose protocol in women under 45 years,and to determine the cutoff value of these parameters and their correlations for predicting low and high ovarian response.Methods:This prospective study included 462 women with the mean age of(29.3±6.5)years.All women were subjected to the GnRH antagonist stimulation multiple-dose protocol.On the second day of the menstrual cycle,ultrasonography was conducted to determine AFC in both ovaries.Peripheral blood samples were collected to evaluate the level of estradiol,FSH,luteinizing hormone,prolactin,thyroid-stimulating hormone,and AMH.The women were divided into three groups:low response(AHH<1 ng/mL,n=173),normal response(AMH=1.0-3.5 ng/mL,n=175),and high response(AMH>3.5 ng/mL,n=114).Results:A significant decrease was found in the age and FSH level in the high response group compared to other groups(P<0.001).Conversely,a significant increase was shown in AMH,estradiol on human chorionic gonadotropin(hCG)day,AFC,mature oocytes,fertilized oocytes,and embryos transferred in the high response group compared to the other two groups(P<0.001).The receiver operating characteristic(ROC)curves demonstrated that AFC and AMH had the highest accuracy,followed by basal FSH level and age in the prediction of low ovarian reserves(P<0.001)with cutoff values of≤4.50 and≤0.95 for AFC and AMH,respectively.Moreover,the ROC analysis showed that AFC had the highest accuracy,followed by AMH level and age in the prediction of high ovarian reserves with a cutoff value of≥14.50,≥3.63,and≤27.50 years,respectively(P<0.01).A significant decrease was observed in women's age,estradiol level,and oocyte fertilization rate in pregnant women compared to non-pregnant women(P<0.001).Additionally,significant negative correlations were found between the AFC,the number of mature oocytes,fertilized oocytes,embryos transferred,and the age of pregnant women(P<0.001).Conclusions:AFC and AMH predict low and high ovarian response to GnRH antagonist stimulation multiple-dose protocol in women under 45 years.

Elective oocyte freezing for the preservation of fertility

Oocyte cryopreservation has recently emerged as an option for women to preserve their fertility for medical (e.g. treatable malignancy) or elective indications (e.g. advancing age). This report describes an IRB-approved study of over 200 oocyte cryopreservation cycles at one center. Patients presenting for oocyte cryopreservation (January 2005 to 2010) were analyzed for day 3 follicle stimulating hormone (FSH), basal antral follicle count (BAFC), gonadotropin usage and the number of oocytes retrieved and cryopreserved. New patient consultations were performed on 516 women, of whom 175 (34%) proceeded to initiate a total of 233 cryopreservation cycles. Twenty-four cycles were cancelled (10%) after starting follicular stimulation due to poor ovarian response or self-withdrawal of the patients. Patients whose cycles were cancelled demonstrated a higher Day 3 FSH and a lower BAFC than patients who completed cycles (p < 0.01). In the 209 completed cycles, the most important predictors of a successful cycle included BAFC (r = 0.36), FSH (r = –0.25) and age (r = –0.18) with the mean number of oocytes cryopreserved at 13.6 ± 8.8. Information about long-term fertility preservation must reach both patients and health care providers so that more women can be educated about the benefits of proactive early physiological reproductive assessment and possible interventions available.

Effect of Diane-35 on Polycystic Ovarian Syndrome of Different Subtypes

Objective: To explore the effect of Daine-35 on serum hormone and antral follicle count of different subtypes of polycystic ovarian syndrome (PCOS). Methods: 138 cases of PCOS were recruited and typed according to Rotterdam diagnostic criteria;78 cases of tubal infertility without hyperandrogenism and menstrual disorders during the same period were collected as control. Serum reproductive hormones including follicle-stimulating hormone (FSH), luteotropic hormone (LH), prolactin (PRL), estradiol (E2), dehydroepiandrosterone (DHEAS), total testosterone (TT) and fast insulin (INS) were determined by chemiluminescent immunoassay. Ovarian antral follicle count was determined by ultrasonography. The effects on above indexes were evaluated for different subtypes of PCOS after 3 cycles of treatment with Daine-35. Results: The cases of Type A and Type B were respectively 43 (31.2%) and 73 (52.9%). They were the most common clinical phenotypes of PCOS in the central region ofChina. Total testosterone (TT) and DHEAS levels of Types A, C and D were higher than those of the control group (p < 0.05). The LH, LH/FSH, INS and HOMA-IR levels in all types of PCOS were higher than those of the control group (p < 0.05). Antral follicle counts of Types A, B and D were more than those of Type C and the control group (p < 0.05). After treatment with Daine-35 for 3 cycles, the serum TT levels of Types A, C and D decreased (p < 0.05). DHEAS values also decreased, but not significantly (p > 0.05). The serum LH and LH/FSH as well as the antral follicle count of all the PCOS types significantly decreased (p < 0.01). Conclusion: Type A and Type B are the most common clinical phenotypes of PCOS in the central region of China. Taking Daine-35 for 3 cycles can significantly reduce the serum androgen, serum LH, LH/FSH ratio, and antral follicle count of different PCOS types.

针刺联合药膳治疗早发性卵巢功能不全临床研究

目的:观察针刺疗法联合药膳治疗早发性卵巢功能不全(POI)的临床疗效。方法:收集2021年9月—2023年9月福建中医药大学附属南平市人民医院诊治的POI患者共60例,按随机数字表法分为观察组与对照组各30例。观察组采用针刺联合药膳治疗,对照组采用芬吗通治疗。比较2组治疗3、6个月后性激素[促卵泡生成素(FSH)、FSH/促黄体生成素(LH)、雌二醇(E2)、抗米勒管激素(AMH)]水平、窦卵泡计数(AFC)、子宫体积、双侧卵巢体积平均值及改良Kupperman评分。结果:治疗3、6个月,2组FSH、FSH/LH水平均较治疗前降低(P<0.05),且呈降低趋势(P<0.05);2组AMH、E2水平均较治疗前升高(P<0.05),且呈升高趋势(P<0.05);但2组相同时间点AMH(除治疗6个月外)、FSH、FSH/LH、E2水平比较,差异均无统计学意义(P>0.05);治疗6个月,观察组AMH水平高于对照组(P<0.05)。治疗3、6个月,2组AFC、子宫体积、双侧卵巢体积平均值均较治疗前升高(P<0.05);但2组相同时间点AFC(除治疗3、6个月外)、子宫体积、双侧卵巢体积平均值比较,差异均无统计学意义(P>0.05);治疗3、6个月,观察组AFC大于对照组(P<0.05)。治疗3、6个月,2组改良Kupperman评分均较治疗前降低(P<0.05);但2组相同时间点改良Kupperman评分比较,差异无统计学意义(P>0.05)。结论:针刺疗法联合助巢煲治疗在改善FSH、FSH/LH、E2水平、子宫体积、双侧卵巢体积平均值、改良Kupperman评分方面与芬吗通相似;当治疗6个月后,针刺疗法联合助巢煲治疗在改善AFC及AMH方面均优于芬吗通。

Rejuvenation of Ovary and Thin Endometrium by Autologous PRP Injection in POR and Recurrent Implantation Failure

In India, the problem of infertility is growing and in the last 5 years, it has gone up to 20% - 30%. This ongoing prospective clinical study brings forth a novel, innovative, effective, simple, affordable, easily performed outpatient procedure (OP) and a promising therapeutic method in rejuvenating the Ageing Ovaries and Thin Endometrium, with autologous Platelet Rich Plasma (PRP). This clinical study proves to give a better result in rejuvenating Ovary and treating the Thin Endometrium. This pilot study included five women (28 - 44 years) with Poor Ovarian Response (POR), Premature Ovarian Insufficiency (POI) and Perimenopause and Thirty-nine women (22 - 43 years.) with recurrent implantation failure due to Thin Endometrium were subjected to autologous PRP instillation under Ultrasound Guidance, and Hysteroscopic guided PRP. After PRP, a significant output was obtained, with improved Anti Mullerian Hormone (AMH) and Antral Follicle Count (AFC) and out of five women three women conceived by Intra Cytoplasmic Sperm Injection (ICSI). PRP injected in women with Poor Ovarian Response found successful ovarian rejuvenation within 1 - 3 months and had a 60% of pregnancy rate, PRP into the endometrium had 53.8% successful pregnancies. We have not encountered any complications.

Anti-Müllerian hormone, antral follicle count and folliclestimulating hormone for predicting the number of oocytes retrieved in IVF/ICSI cycles

Objective To evaluate the efficacy of anti-Müllerian hormone（AMH）, antral follicle count（AFC） and follicle-stimulating hormone（FSH） for predicting the number of oocytes retrieved in in-vitro fertilization/intracytoplasmic sperm injection（IVF/ICSI）cycles.Methods In this retrospective study, a total of 122 infertile women were divided into two groups： group A, 〈35 years（n=71）; group B, ≥35 years（n=51）. AMH and FSH were determined on 2-5 d of the early menstrual cycle. AFC was tested on the second day of the menstrual cycle before the start of stimulation.Results Group B had higher FSH levels compared with group A（8.2±3.5 IU/L vs 6.8±2.4 IU/L, P〈0.05）. However, levels of AMH and AFC in group B were lower than those of group A（AMH： 4.2±3.5 μg/L vs 2.7±2.7 μg/L; AFC： 9.0±3.9 vs 5.4±3.3, P〈0.05）. The number of oocyte retrieved in the two groups was not significantly different（11.5±6.8 vs 9.6±6.9, P〉0.05）. The level of AMH was more strongly correlated with the number of oocytes retrieved than that of AFC or FSH level. The strengths of the correlation degrees were AMH level, AFC, and FSH level in turn（r=0.600, 0.511,-0.369）.Conclusion AMH would be a useful predictor for ovarian response.

针药结合助卵养巢法治疗肾虚血瘀型卵巢储备功能减退的临床观察

目的:探讨针药结合助卵养巢法治疗肾虚血瘀型卵巢储备功能减退的临床疗效。方法:将60例肾虚血瘀型卵巢储备功能减退患者随机分为观察组和对照组,每组30例。观察组接受针药结合助卵养巢法治疗,对照组接受西药人工周期法治疗。两组均治疗3个疗程。比较两组患者治疗前后中医证候积分、血清性激素水平、抗苗勒氏管激素(Anti Miillerian Hormone,AMH)水平及双侧窦卵泡数(Antral Follicle Count,AFC),比较两组综合治疗疗效及不良反应发生情况。结果:经过治疗,两患者中医证候积分均较治疗前显著降低(P<0.01),且观察组在降低中医证候积分方面较对照组更优(P<0.05);治疗后两组患者的血清性激素卵泡刺激素(Follicle-Stimulating Hormone,FSH)、促黄体生成素(Luteinizing Hormone,LH)和FSH/LH水平均显著降低(P<0.01),血清雌二醇(Estradiol,E2)水平均显著升高(P<0.01),组间差异无统计学意义(P>0.05);治疗后,两组患者的血清AMH水平和AFC值均显著增加(P<0.01),且观察组在提高AMH水平和AFC值方面均明显优于对照组(P<0.05,P<0.01);观察组的总有效率高于对照组,但差异无统计学意义(P>0.05);观察组不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论:针药结合助卵养巢法能有效治疗肾虚血瘀型卵巢储备功能减退,在提高AMH、增加AFC方面表现出更佳的效果,且无不良反应,值得临床推广使用。

多囊卵巢综合征患者血清抗米勒管激素和窦卵泡计数水平与卵巢储备功能下降的相关性

目的 探究多囊卵巢综合征(PCOS)患者血清抗米勒管激素(AMH)和窦卵泡计数(AFC)水平及其与卵巢储备功能下降(DOR)发生风险的相关性。方法 选择2021年8月至2022年8月于四川绵阳四○四医院就诊的173例PCOS患者,根据血清卵泡刺激素(FSH)或雌二醇(E_(2))水平,将PCOS患者分为DOR组(45例)和非DOR组(128例),比较两组患者的一般资料及生化指标、AMH和AFC水平及卵巢储备功能相关指标。采用Pearson检验分析PCOS合并DOR患者中AMH、AFC与卵巢储备功能指标的相关性,构建PCOS患者发生DOR的列线图预测模型,并评估其预测效能及准确度和有效性。结果 DOR组患者的AMH、AFC水平明显低于非DOR组,年龄、黄体生成素(LH)、FSH、FSH/LH、E_(2)、睾酮(T)明显高于非DOR组(t=7.417、10.598、2.681、24.222、7.801、11.334和156.602,P<0.05),AMH、AFC分别与FSH、LH、FSH/LH、T呈显著负相关,与E_(2)呈显著正相关(r=-0.574、-0.566、-0.547、-0.528和0.496;t=-0.631、-0.584、-0.603、-0.560和0.545,P<0.05),列线图模型的受试者工作特征(ROC)曲线下面积为0.802(0.764~0.840),灵敏度和特异度分别为85.42%、74.05%。结论 PCOS患者血清AMH和AFC水平与卵巢储备功能相关指标具有明显相关性,与DOR的发生密切相关,对预测PCOS患者发生DOR具有较高价值。

滋肾益经活血汤治疗肾虚血瘀型卵巢储备功能减退的疗效及对T淋巴细胞亚群水平的影响

目的:探讨滋肾益经活血汤治疗肾虚血瘀型卵巢储备功能减退(DOR)的疗效及对T淋巴细胞亚群水平的影响。方法:选取2019年4月至2022年4月陕西省中医医院收治的肾虚血瘀型DOR患者120例作为研究对象,按照随机数字表法随机分为观察组和对照组,每组60例。对照组接受戊酸雌二醇环丙孕酮片治疗,观察组在对照组基础上接受滋肾益经活血汤治疗。治疗6个月经周期后,比较2组患者临床疗效和治疗后中医证候积分、窦卵泡计数(AFC)、卵巢动脉血流参数、促卵泡激素(FSH)、雌二醇(E_(2))、抗米勒管激素(AMH)、月经情况、T淋巴细胞亚群水平及不良反应发生率。结果:治疗后,观察组治疗总有效率为88.33%(53/60)高于对照组的71.67%(43/60),差异有统计学意义(P<0.05)。治疗前,2组中医证候积分、AFC、FSH、E_(2)、AMH、卵巢动脉血流参数、月经情况和T淋巴细胞亚群水平比较,差异无统计学意义(P>0.05);治疗后,观察组中医证候积分、FSH、CD8^(+)、阻力指数和月经周期、月经色质、月经量、经期评分低于对照组,AFC、舒张末期流速、收缩期峰值速度、E_(2)、AMH、CD3^(+)、CD4^(+)、CD4^(+)/CD8^(+)高于对照组,差异有统计学意义(P<0.05)。2组患者不良反应率比较,差异无统计学意义(P>0.05)。结论:滋肾益经活血汤治疗肾虚血瘀型DOR疗效显著,能有效改善患者临床症状、卵巢储备功能、月经异常和免疫功能,且不良反应较少。

探讨对卵巢储备功能采取AMH及AFC计数预测的价值

目的 探讨对卵巢储备功能采取AMH和AFC计数进行预测的价值。方法 回顾性分析本院2022年1月—2023年6月妇科门诊接诊的90例患者作为研究对象,按照卵巢储备功能的差异分为对照组(卵巢功能正常)和观察组(卵巢功能减退),每组45例,对两组患者的抗缪勒管激素(AMH)、窦卵泡数(AFC)、雌二醇(E2)、促卵泡生成素(FSH)及FSH与促黄体生成素(LH)的比值(FSH/LH)进行对比,并以Logistic二元回归分析对具有统计学差异的指标与卵巢储备功能的相关性进行分析。结果 两组在AMH和AFC指标方面的差异存在统计学意义(P<0.05),对两项指标与卵巢储备功能的相关性进行分析,发现AMH、AFC是影响患者卵巢储备功能的关键指标。ROC分析结果提示AMH、AFC联合进行卵巢储备功能预测时,敏感度为88.90%,特异度为88.89%。结论 AMH和AFC计数在卵巢储备功能早期评估及预测方面具有良好的价值。

基础窦状卵泡数结合年龄用于评估卵巢储备及预测卵巢低反应和体外受精临床结局

目的选取基础窦状卵泡数(AFC)≤10个、年龄≥38岁初步作为界定卵巢储备减退的标准,研究在体外受精-胚胎移植(IVF-ET)治疗中通过AFC结合年龄评估卵巢储备、预测卵巢反应以及临床结局的价值。方法回顾性队列研究2003年1月～2008年12月于我院行IVF-ET治疗的AFC≤10个的患者共1319周期。根据AFC数目进行分组,A组:AFC<5个,B组AFC为5～7个,C组AFC为8～10个,同时按患者年龄分为<38岁组和≥38岁组,比较各组患者的基本临床特征、获卵数及临床结局等的差异。结果从A组至C组Gn使用量逐渐增大、可抽吸卵泡数和获卵数逐渐减少,其差异有显著性(P<0.001)。年龄<38岁组Gn使用量显著大于≥38岁组,抽吸卵泡数和获卵数显著高于≥38岁组(P<0.05)。AFC≤7个且年龄<38岁组卵泡数、获卵数少于AFC>7个且年龄≥38岁组,Gn总量前者大于后者,临床妊娠率、分娩率前者高于后者。运用双变量相关分析以及多元线性回归分析获卵数与年龄及基础AFC、基础FSH的关系,得出AFC为卵巢反应性最佳单项预测指标。不同AFC组间患者临床妊娠率有显著性差异,早期自然流产率≥38岁组要明显高于年龄<38岁组。结论任何年龄妇女AFC≤7个或年龄≥38岁则AFC≤10个是卵巢储备降低较为合适的界定指标,若年龄>40岁则AFC≤10个,出现卵巢低反应的几率高,AFC结合年龄是评估卵巢储备、预测卵巢反应性的最佳指标。年龄对于临床妊娠的预测价值,优于AFC。AFC主要影响卵子数量,而年龄主要影响卵子数量及质量。

在体外受精-胚胎移植中应用多项卵巢储备功能评估指标预测卵巢反应性

目的分析卵巢储备功能评估指标与卵巢反应性的关系及对卵巢反应性的预测效能。方法队列研究分析行体外受精(IVF)/单精子卵母细胞内注射(ICSI)的331个取卵周期病例,并将病例分为正常反应组、低反应组以及高反应组3组,采用ELISA方法检测患者月经第3天的血清抗苗勒氏激素(AMH)水平,同时超声测量双侧卵巢内基础窦状卵泡数(AFC),血清基础卵泡刺激素(FSH)、黄体生成素(LH)及雌激素(E2)采用化学免疫发光法检测。结果血清AMH水平、AFC、血清FSH水平、FSH与LH比值(FSH/LH)、年龄均与获卵数×1000/促性腺激素(Gn)总安瓿数相关(P<0.001);而基础E2与其不相关(P>0.05)。AFC及血清AMH水平作为单一指标对于卵巢低反应的预测价值最好,其ROC曲线下面积分别为0.855(0.787-0.924)和0.832(0.764-0.900),对卵巢低反应的最佳预测界值点分别为AFC≤9个,AMH≤1.88 ng/ml。AFC是预测卵巢高反应的最好单一指标,其ROC曲线下面积为0.787(0.728-0.847),最佳预测界值点为AFC≥15个。Logistic逐步回归分析显示联合AFC、血清AMH水平以及血清FSH水平指标能更好地预测卵巢低反应,但联合各指标并不能提高对卵巢高反应的预测效能。结论 AFC、血清AMH水平、血清FSH水平、FSH/LH、年龄均是卵巢反应性的预测指标,但是其敏感性、特异性不同。AFC作为单一指标对于卵巢反应的预测价值最好。联合AFC、血清AMH水平及血清FSH水平能提高对于卵巢低反应的预测效能。而对于卵巢高反应,联合多指标不能提高预测效能。

全子宫与次全子宫切除术治疗子宫肌瘤对女性卵巢功能的影响

目的:对比全子宫与次全子宫切除术治疗子宫肌瘤对女性卵巢功能的影响。方法:选择2011年9月到2015年2月在我院诊治的子宫肌瘤患者146例,根据随机数字表法分为治疗组73例与对照组73例,对照组给予经腹全子宫切除术,治疗组给予经腹次全子宫切除术。结果:治疗组的手术时间、术中出血量、术后肛门排气时间与术后住院时间明显少于对照组(P<0.05)。治疗组术后1个月恶心、呕吐、皮下气肿、下肢静脉血栓、阴道感染等并发症明显少于对照组(P<0.05)。治疗组与对照组术后1个月窦卵泡计数分别为8.89±1.03个和6.19±1.33个,都明显低于术前11.39±2.98个和11.33±2.10个(P<0.05),但两组术后1个月比较差异有统计学意义(P<0.05)。两组术后1个月的血清雌二醇(E2)值明显低于术前(P<0.05),而血清卵泡刺激素(FSH)值明显高于术前(P<0.05),但组间比较差异都无统计学意义(P>0.05)。结论:子宫切除术对卵巢功能均有一定的负面影响,但次全子宫切除术对AFC的影响更小,减少术后并发症的发生,有较好的应用价值。

阴道彩超预测基础FSH水平正常患者超排卵中卵巢反应性的价值

目的探讨经阴道彩色多普勒测量早卵泡期窦卵泡计数(antralfolliclecount,AFC)及卵巢基质血流峰值流速(stromalpeaksystolicvelocity,PSV)、阻力指数(resistanceindex,RI)在预测基础卵泡刺激素(basalfolliclestimulatinghormone,bFSH)水平正常患者促性腺激素释放激素激动剂(GnRH-α)短方案超排卵(controlledovarianhyperstimulation,COH)治疗中卵巢反应性的价值。方法2003年9月￣2004年8月在该院生殖医学中心接受体外受精(in-vitrofertilization,IVF)或单精子胞浆内注射(intracytoplasmicsperminjection,ICSI)助孕治疗的不孕症患者,bFSH水平为该中心行IVF的正常值范围。于月经第2天行阴道彩超检查,测量早卵泡期AFC及PSV、RI,并在当周期行GnRH-α短方案COH治疗,观察获卵数以判断卵巢的反应性。结果45例bFSH水平正常患者接受COH治疗,在匹配了年龄和bFSH水平后观察到反应正常组与反应不良组AFC与PSV差异有显著性,外源性卵泡刺激素用量及刺激时间差异有显著性,而RI差异无显著性。促排卵反应不良病史也是卵巢低反应性的影响因素。结论经阴道彩超测量早卵泡期AFC及PSV是bFSH水平正常患者进行GnRH-α短方案COH前评价卵巢反应性的较好指标。

中重度卵巢过度刺激综合征最佳预测因素的初步探讨

目的探讨中、重度OHSS发生的最佳预测指标,以期更好地指导临床工作,降低中、重度OHSS的发生。方法回顾性分析2014年1月至2018年7月于本中心接受IVF/ICSI-ET治疗的5 225个周期的临床资料。选择发生中、重度OHSS进行住院治疗的45例患者作为OHSS组;选择同期接受IVF治疗、但未发生OHSS的53例患者作为非OHSS组。比较两组之间促排卵过程中的临床数据和实验室数据,并对筛选出的危险因素做回归分析,利用ROC曲线确定诊断界值。结果 (1)中、重度OHSS的发生率为0.86%,发生时间为取卵后(13.9±5.3)d;进行新鲜移植的患者为37例,均成功妊娠。(2)OHSS组的PCOS患者比例和窦卵泡数均显著高于非OHSS组(P<0.05);OHSS组的Gn用量、HCG日的E_2值和直径大于11mm的卵泡数均显著高于非OHSS组(P<0.05)。(3)窦卵泡数与OHSS发生有关,且为独立危险因素(P<0.05)。(4)ROC曲线显示AFC的诊断界值为≥16.5个,敏感性为70.5%,特异性为66%;HCG日直径大于11mm的卵泡数的诊断界值为≥13.5个,敏感性为79.5%,特异性为56.6%;HCG日E_2水平的诊断界值为≥13 347.79pmol/L。结论窦卵泡数≥16.5时能够更好地预测中、重度OHSS的发生,其次是HCG日直径在11mm以上的卵泡数≥13.5时能够较好的预测中、重度OHSS的发生。

抗苗勒管激素预测卵巢反应性的价值研究

目的:评价抗苗勒管激素(AMH)对卵巢反应性的预测价值。方法:以1489例行体外受精-胚胎移植(IVF-ET)治疗的不孕患者作为研究对象,分别以获卵数≤3个和>20个界定卵巢低和高反应,比较AMH和其他卵巢储备评估指标预测卵巢反应性时的受试者工作特征曲线面积(ROCAUC)。结果:预测卵巢低反应或高反应时,AMH和窦卵泡计数(AFC)的ROCAUC均相当(分别为0.867和0.860,P=0.319;0.772和0.753,P=0.287),且明显大于年龄、基础卵泡刺激素(FSH)和基础雌二醇(E2)的ROCAUC(分别为0.685、0.723和0.600,P均<0.001;0.679、0.650和0.501,P均<0.001)。AMH≤8.5 pmol/L或AFC≤9时可较好地预测卵巢低反应,而AMH>29.77 pmol/L或AFC>16时则可较好地预测卵巢高反应。结论:AMH独立预测卵巢反应性的价值与AFC相当,二者均明显优于年龄、基础FSH和基础E2。

窦卵泡计数及卵巢动脉血流变化与助孕术治疗结局的关系探讨

目的:探讨助孕术前子宫、卵巢的血流动力学变化及窦卵泡数与IVF-ET治疗后妊娠结局的关系。方法:129例拟采用IVF-ET助孕技术治疗的不育症患者,经阴道彩色多谱勒分别检测子宫体积、内膜厚度、血液动力学变化和卵巢体积、血液动力学以及窦卵泡数,比较分析上述指标与IVF-ET后成功妊娠的关系。结果:妊娠成功组的卵巢基质血流PI及RI、S/D指标显著小于妊娠失败组,而卵巢体积、窦卵泡数显著大于妊娠失败组,但是妊娠与否与子宫的相关参数无关。结论:卵巢动脉的PI、RI、S/D、卵巢体积和窦卵泡数数与妊娠结局有密切的关系。

应用ROC曲线评估年龄、窦卵泡数及基础卵泡刺激素预测卵巢储备功能的价值

目的:探讨年龄、窦卵泡数(antral follicle count,AFC)、基础卵泡刺激素(bF-SH)预测卵巢储备功能的价值。方法:应用受试者工作特征曲线(ROC),回顾性分析本中心2003年1月～2009年12月6387例应用长方案行体外受精/卵细胞内单精子注射-胚胎移植(IVF/ICSI-ET)患者的临床资料。结果:(1)年龄、AFC与bFSH预测卵巢低反应的ROC曲线下面积AUCl、AUC2、AUC3分别为0.69、0.86、0.70,均大于机会参考线下面积(P<0.05),AUC2大于AUCl及AUC3,差异有统计学意义(Z12=9.43,Z23=8.21,P均<0.05),AUCl及AUC3差异无统计意义(Z13=0.35,P>0.05)。(2)年龄、AFC与bFSH预测临床妊娠的ROC曲线下面积AUC4、AUC5、AUC6分别为0.57、0.55、0.53,均大于机会参考线下面积(P<0.05),AUC4大于AUC5及AUC6,差异有统计学意义(Z45=2.21,Z46=3.98,P均<0.05),AUC5与AUC6差异无统计意义(Z56=1.77,P>0.05)。(3)AUCl值、AUC2值、AUC3均分别显著大于AUC4、AUC5、AUC6(Z14=7.18,Z25=24.75,Z36=9.31,P均<0.05)。结论:年龄、AFC及bFSH均能预测卵巢的储备功能。对于卵巢低反应的预测价值,AFC高于年龄及bFSH。对于临床妊娠的预测价值,年龄高于AFC及bFSH。且年龄、AFC及bFSH对卵巢低反应的预测价值均高于对临床妊娠的预测价值。

卵泡输出率、窦卵泡计数结合年龄评估卵巢反应性及预测体外受精临床结局的研究

目的:探讨卵泡输出率(Follicular Output Rate,FORT)、窦卵泡计数(antral follicle count,AFC)结合年龄评估卵巢反应性及预测体外受精临床结局的价值。方法:选择2014年6月至2016年6月连云港市妇幼保健院生殖中心行体外受精-胚胎移植的不孕症妇女,选择长方案促排卵治疗,共纳入197个治疗周期,新鲜周期获得治疗结局159个周期,分三个年龄组、三个AFC组,三个FORT组,分别比较临床资料、促排卵资料、实验室和临床结局等指标,评价年龄、AFC、FORT三个指标与卵巢反应及治疗结局的相关性以及三个指标之间的相关性分析。结果:妊娠组与非妊娠组比较,妊娠组的FORT、受精率、优质胚胎率均较非妊娠组高,差异具有统计学意义。随着年龄增加,Gn用量增加,注射人绒毛膜促性腺激素(human chorionic gonadotrophin,HCG)日当天雌二醇(estradiol,E_2)、获卵数、受精率、优质胚胎率、临床妊娠率及种植率均降低,差异具有统计学意义,但FORT在三种年龄段内无差异。三个不同AFC组相比较,随着AFC的增加,获卵数增加,实验室及临床结局指标无统计学差异。高、中、低FORT组比较,HCG日E_2在高FORT组中最高,在低FORT组中最低。获卵数、优胚率、临床妊娠率、胚胎种植率在低、中、高三组间逐步升高,差异有统计学意义。FORT、AFC、年龄三者之间无相关性。结论:联合年龄、AFC、FORT三种指标可以有效预测卵子的数量、质量、卵巢的反应性以及治疗结局。